MichaelDriscollToboniMD

Obstetrics & Gynecology • Saint Louis, MO

Gynecologic Oncology

Fellow Physician

Join to view full profile

Dr. Toboni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Toboni's full profile

Already have an account?

Office
4901 Forest Park Avenue
9th Floor, COH, Suite 905
Saint Louis, MO 63130
Phone+1 415-317-4252
Is this information wrong?

Education & Training

University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 2015 - 2019
Keck School of Medicine of the University of Southern CaliforniaClass of 2015

Certifications & Licensure

AL State Medical License 2016 - 2024
MO State Medical License 2019 - 2023
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Publications & Presentations

PubMed

Management of a complete mole and coexisting fetus in post-dobbs world.
Damien Roland, Jordan Barton Garcia, Angela R Seasely, Hua Guo, Margaret Boozer, Gabriella Cozzi, Michael D Toboni> ;Gynecologic Oncology Reports. 2024 Apr 1
1 citations
Differential responses to immune checkpoint inhibitors are governed by diverse mismatch repair gene alterations.
Khushman, M., Toboni, M., Xiu, J., Manne, U., Farrell, A., Lou, E., Shields, A., Philip, P., Salem, M., Abraham, J., Spetzler, D., Marshall, J., Jayachandran, P., Hall...> ;Clinical Cancer Research. 2024 Feb 13
2 citations
Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair ge...
Michael D Toboni, Sharon Wu, Alex Farrell, Joanne Xiu, Jennifer R Ribeiro, Matthew J Oberley, Rebecca Arend, Britt K Erickson, Thomas J Herzog, Premal H Thaker, Matthe...> ;Gynecologic Oncology. 2023 Oct 1
3 citations
Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study.
Michael D Toboni, Alexander Cohen, Zachary L Gentry, Stuart A Ostby, Zhixin Wang, Sejong Bae, Charles Leath> ;International Journal of Gynecological Cancer. 2022 Jun 6
3 citations
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer
Michael D. Toboni, Elena Lomonosova, Shaina Bruce, Joan Tankou, Mary M. Mullen, Angela Schab, Alyssa Oplt, Hollie Noia, Danny Wilke, Lindsay M. Kuroki, Andrea R. Hagem...> ;Cancers. 2021 Nov 23
6 citations
New Treatments for Recurrent Uterine Cancer.
Michael D. Toboni, Matthew A. Powell> ;Current Oncology Reports. 2021 Nov 4
12 citations
GAS6/AXL inhibition enhances ovarian cancer sensitivity to chemotherapy and PARP inhibition through increased DNA damage and enhanced replication stress
Mary M. Mullen, Elena Lomonosova, Michael D. Toboni, Alyssa Oplt, Emily Cybulla, Barbara Blachut, Peinan Zhao, Hollie Noia, Daniel Wilke, Erinn B. Rankin, Lindsay M. K...> ;Molecular Cancer Research. 2021 Oct 20
1 citations
Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer.
E.A. Johns, Jennifer A. Stanley, Michael D. Toboni, Julie K. Schwarz, F. Zhang, Andrea R. Hagemann, Katherine Fuh, Premal H. Thaker, Carolyn K. McCourt, David G. Mutch...> ;Gynecologic Oncology Reports. 2021 Jun 9
9 citations
Uterine carcinosarcomas: From pathology to practice.
Michael D. Toboni, Erin K. Crane, Jubilee Brown, Alexander Shushkevich, Sarah Chiang, Brian M. Slomovitz, Douglas A. Levine, Sean C. Dowdy, Ann H. Klopp, Matthew A. Po...> ;Gynecologic Oncology. 2021 Jul 1
5 citations
State of the science: Uterine sarcomas: From pathology to practice.
Alexander Shushkevich, Premal H. Thaker, Ramey D. Littell, Naishadh A. Shah, Sarah Chiang, Katherine Anne Thornton, Martee L. Hensley, Brian M. Slomovitz, Kevin Holcom...> ;Gynecologic Oncology. 2020 Aug 21
3 citations
Reducing emergency department (ED) computed tomography (CT) utilization in women treated for gynecologic cancers.
Stuart A. Ostby, Joel G. Evans, Haller J. Smith, Teresa K.L. Boitano, Michael D. Toboni, Matthew A. Heimann, J. Stu Booth, Jarred J. Thomas, J. Michael Straughn> ;Gynecologic Oncology. 2020 Feb 1
20 citations
Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.
Rebecca C. Arend, Michael D. Toboni, Allison M. Montgomery, Robert A. Burger, Alexander B. Olawaiye, Bradley J. Monk, Thomas J. Herzog> ;The Oncologist. 2018 Dec 1
6 citations
Vulvar Cancer as a Result of GATA2 Deficiency, a Rare Genetic Immunodeficiency Syndrome
Michael D. Toboni, Kerri S. Bevis> ;Obstetrics and Gynecology. 2018 Nov 1
1 citations
Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program Database.
Michael D. Toboni, Haller J. Smith, Sejong Bae, J. Michael Straughn, Charles A. Leath> ;International Journal of Gynecological Cancer. 2018 Sep 1
2 citations
Malignant Brenner tumor associated with a germline BRCA2 mutation
Michael D. Toboni, Haller J. Smith, Sarah E. Dilley, Lea Novak, Charles A. Leath> ;Gynecologic Oncology Reports. 2017 Aug 1
7 citations
Contributing factors for menopausal symptoms after surgical staging for endometrial cancer.
Koji Matsuo, M. Gualtieri, Sigita S. Cahoon, Michael D. Toboni, Hiroko Machida, Aida Moeini, Kosei Hasegawa, Donna Shoupe, Lynda D. Roman> ;Menopause. 2016 May 1
Join now to see all